Clinical Trial Update: Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 clinical trial evaluating glecaprevir/pibrentasvir for post-traumatic stress disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Glecaprevir/pibrentasvir (glecaprevir/pibrentasvir)

Snippet

Sponsor: White River Junction Veterans Affairs Medical Center | Conditions: PTSD | Phase 2, Phase 3 | Status: RECRUITING